DCSIMG

Public / About us / Research and Development / Scientific Network

Scientific Network

Scientific Network

Our network includes partners from academia and industry in this field, for example

  • Avid Radiopharmaceuticals Inc., USA, to design novel tracers for the early detection of Alzheimer’s disease;
  • Taisho Pharmaceutical Co., Ltd. in Japan to develop tracers for imaging of neuroinflammation;
  • FutureChem Co., Ltd. in South Korea in the field of labeling technologies;
  • Stanford University, USA, to identify new tracer compounds for imaging tumors;
  • and the Swiss Federal Institute of Technology (ETH), Zurich, Switzerland, in the area of PET imaging.

Detailed information for Healthcare Professionals

Contrast Media

Bayer HealthCare Pharmaceuticals - leader in developing and manufacturing of contrast media worldwide

more
Bayer presents positive Phase II data with florbetaben

Potential to visualize beta-Amyloid plaques in Patients with Alzheimer’s disease demonstrated / Florbetaben may innovate the diagnostic capabilities

more

Welcome to the Public Area of Diagnostic Imaging

If you are a healthcare professional, please enter the professional’s website:

Font size
- 1 2 3 + Font size

click to adjust

Login

To access the physicians' part of our website, please click on the lumen of the trachea in the CT image below.

. Username . Password
Disclaimer
  • This website is intended to provide information to an international audience outside the USA and UK.
http://www.imaging.bayer.com/scripts/pages/en/public/about_us/research_and_development/scientific_ne
twork/index.php
Copyright © Bayer Pharma AG